📌 Key Takeaways
- Topic: Silica as an Anti-Settling Agent: How It Keeps Pigments and Fillers Suspended
- Keywords: silica food additive
- Published: 2026-11-20 05:29:41
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Green Tire Silica? Role in Low Rolling Resistance and Fuel-Efficient Tires
- Colloidal Silica Slurry: Specifications and Uses in CMP and Precision Polishing
- 2.2. Particle Morphology
- Respirable Crystalline Silica OSHA Standard: Exposure Limits and Compliance Requirements
- In the other case, the adsorption capacity of the carriers decreases owing to granulation, which can impair the absorption of the molecules, since the binder can cover the surface of the pores or fill the channels [ 105, 107 ]. To conclude, the optimization of the granulation process is necessary for the drug-carrier complex used. Dry granulation cannot be used as a granulation technique for such carriers, as high compression forces can damage the pore structure [ 98 ].
- Spherical Silica for Semiconductor Packaging: Key Specs, Purity and Selection Guide
- 8. Conclusions
- Spherical Silica Market 2026: Semiconductor Packaging Demand and Growth Outlook
- Oral route is one of the most trustworthy and well-liked ways of drug administration, as it is one of the simplest and most convenient ways for self-medication [ 25, 56 ]. The gastrointestinal system offers an outstanding absorption surface for the introduction of the API into the systemic circulation [ 25 ]. Nevertheless, in the case of molecules with poor water solubility and poor permeability, drug formulation involves many difficulties, which can be solved by using nanocarriers [ 42, 56 ]. Ndayishimiye et al. proved that vancomycin, a high molecular weight and hydrophilic antibiotic macromolecule with poor oral bioavailability, can be effectively encapsulated using silica nanocarriers, and therefore, the necessary oral bioavailability can be made sure to eliminate the injection-related side effects [ 14 ]. The in vitro study showed a prolonged drug release from the nanocarriers compared to the pure drug form, and the in vitro permeability through Caco-2 cells revealed a significant boost in the permeation for the encapsulated drug compared to the unencapsulated form [ 14 ]. These nanocarriers may also protect pH-sensitive molecules from the acidic environment of the stomach, thereby avoiding unwanted chemical changes, and moreover, they may also protect macromolecules from enzymatic degradation [ 25, 56 ]. Based on diverse experiments, several key elements greatly influence the effectiveness of the therapy. The optimal size range was established between 50 and 200 nm [ 13 ]. Particles smaller than this are trapped in the mucus layer, and larger ones cannot pass through the tight junctions [ 13 ]. Anionic surface boosts enteral permeability [ 13, 14 ]. Overall, enteral bioavailability can be improved at several points.
Silica for Sale: How to Find the Right Grade and a Reliable Seller
What is silica (SiO₂)?
fused silica vs quartz
What is the difference between fumed silica and precipitated silica?
colloidal silica supplier
What drives silica raw material prices?
silica density Wet granulation is the most frequently used technique to process MSNs, because of the many possibilities inherent in it [ 106 ]. Conventional wet granulation is well-suited for the granulation of silica nanocarriers, but several things should be considered during implementation. There are two possible sequences: first, the drug loading, followed by the granulation of the loaded carriers [ 104 ], or the opposite way, the granulation of the empty carriers, then loading the drug into the prepared granules. In the first case, during the planning and implementation of the process, special attention must be paid to the critical process parameters to steer clear of premature drug release [ 104 ]. In general, it can be noted that as little moisture as possible should be used during granulation, consequently decreasing the risk of premature drug release. Still, simultaneously, moisture adequate to produce the desired agglomeration must be made sure [ 104 ]. The risk of premature drug release depends to a certain extent on the chemical structure of the API and the carrier. Szewczyk and Prokopowicz developed doxycycline-loaded MSN pellets with prolonged release kinetics [ 40 ]. First, the drug was loaded into the pores, and then pellets were produced from the loaded mesoporous material with other excipients by wet extrusion and spheronization. For comparison, traditional doxycycline pellets were also prepared. This study demonstrated the importance of utilizing mesoporous carriers for the delayed or sustained release of water-soluble drugs. Pelletization was a successful method to reduce the initial burst release of doxycycline; twice the release time was observed compared to traditional pellets [ 40 ]. Szewczyk et al. developed another DDS loaded with an antibiotic compound (cefazolin) for the treatment of osteomyelitis [ 66 ]. The amine-functionalized MSN was successfully loaded with the drug, and because of the powerful interactions between the negatively charged cefazolin and the positively charged surface of the carrier, a prolonged release of 5 days was observed, which made sure a longer antibacterial influence than with classic pellets. This was proven by the microbiological activity assays of the pellets against S. aureus culture [ 66 ]. These results are promising in antibiotic or anticancer therapy, where therapeutic concentration is needed for a longer period [ 40, 66 ]. A comparable outcome was presented in another publication about metformin-containing MSN pellets with prolonged release kinetics [ 85 ]. After drug loading, pellets were formed with the mixture of the preloaded carriers and chitosan solution, and then the pellets were coated with five layers of chitosan. Since the stomach is not considered the best possible absorption surface for metformin, it is advisable to delay the release until conditions in the intestines are ideal for maximum bioavailability. Chitosan plays an important role in this formulation; it slows down and delays the metformin release and offers delayed and prolonged release kinetics, thereby preventing speedy blood level peaks after application [ 85 ]. On the contrary, Wang et al. published a post on MSN pellets filled with poorly water-soluble carbamazepine, and they observed better oral bioavailability compared to commercially available tablets based on in vivo analysis performed on dogs [ 86 ]. In vitro dissolution studies confirmed a raised dissolution rate compared to crystalline carbamazepine due to the amorphous state of the drug within the pores. This immediate-release pellet formulation allows for a reduction in the drug dose, sustaining the same clinical influence [ 86 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.